Sylvain Roy, CTO to present at Cell and Gene Therapy Manufacturing and Commercialization
Sylvain Roy, CTO to prsent at Cell and Gene Therapy Manufacturing and Commercialization September 23-26, 2024 Hynes Convention Center, Boston, MA https://informaconnect.com/cell-therapy-bioprocessing/speakers/sylvain-roy/
Manufacturing of CD19/20 Bispecific CAR T-Cell Therapy (IMPT-514) for the Treatment of Multiple Sclerosis
Ethan BenDavid, Josh Bangayan, Katherine Standley, Orit Foord, Melanie Munguia, Jessica Reyes, Jenny Cui poster presentation at the Consortium of Multiple Sclerosis (CMSC) Annual Meeting May 30, 2024. View PDF
Engineering a Bispecific Claudin 18.2/TGF-β CAR to Target Claudin 18.2 Tumors and Overcome the Tumor Microenvironment
Jessica Reyes, Ethan BenDavid, Orit Foord, Ximin Chen, Michael Weist, Giulia Parisi, Jiajia Cui, and Melanie L. Munguia poster presentation at the American Society of Gene and Cell Therapy (ASGCT) 27th Annual Meeting, May 8, 2024, in Baltimore, Maryland. View PDF
ImmPACT Bio CEO, Sumant Ramachandra, in conversation with Biotech.TV
ImmPACT Bio CEO, Sumant Ramachandra, in conversation with Biotech.TV, Feb. 1, 2024 Link to conversation: https://www.biotechtv.com/post/immpact-bio-february-1-2024